z-logo
open-access-imgOpen Access
Continuous or intermittent walking, the effect on glycated hemoglobin in sedentary employees during 10-week intervention
Author(s) -
Mynor G. Rodríguez-Hernández,
James R. McDonald,
Danielle W. Wadsworth
Publication year - 2021
Publication title -
international journal of physical education fitness and sports
Language(s) - English
Resource type - Journals
eISSN - 2457-0753
pISSN - 2277-5447
DOI - 10.34256/ijpefs2114
Subject(s) - glycated hemoglobin , medicine , hemoglobin , physical therapy , post hoc analysis , sedentary behavior , type 2 diabetes , diabetes mellitus , physical activity , endocrinology
To examine long term changes on glycated hemoglobin in sedentary employees exposed to two different walking programs during a 10-week intervention. A total of 68 sedentary employees participated in a 10week walking intervention and were randomly assigned to one of three groups: intermittent walking, continuous walking or control group. Hemoglobin A1cNOW+ device tested glycated hemoglobin and accelerometry assessed physical activity. Results showed glycated hemoglobin significantly decreased over the ten weeks (5.82±0.49, 5.66±0.44) F(1,64) =4.229, p=.044) in the continuous walking group. Post-Hoc test showed the continuous walking group was significantly affected, F=8.463, p=.009, with a large size effect n2=.297. There were no changes within the intermittent group (5.69±0.63, 5.63±0.6) or control group (5.59±0.6, 5.6±0.54) (p>0.05). Accelerometry showed a main effect of time by group interaction F(4,124) =4.688, p=0.001). Post-Hoc indicated that the continuous walking group took significantly longer bouts of moderate to vigorous intensity walking at week-6 compared to pre-test (p=0.006) at this could have influenced the results, there were no changes in the length of bouts in the intermittent or control groups (p>0.05). Sedentary employees who perform a moderate intensity continuous walking program show benefits in controlling blood glucose, thereby, reducing the risk of developing type 2 diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom